We are live on ! Find out more
MRUS

Merus

Delisted

MRUS was delisted on the 29th of December, 2025.

11 hedge funds and large institutions have $103M invested in Merus in 2016 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

30.3% more ownership

Funds ownership: 0%30.3% (+30%)

25% more capital invested

Capital invested by funds: $82.3M → $103M (+$20.4M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

8% less funds holding

Funds holding: 1211 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

Holders
11
Holders Change
-1
Holders Change %
-8.33%
% of All Funds
0.28%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
1
Increased
2
Reduced
5
Closed
2
Calls
Puts
Net Calls
Net Calls Change

MRUS Hedge Fund Activity: Q4 2016 in Review

11 of the 3,983 institutional investors tracked by Wall St. Rank reported a position in Merus (MRUS) for Q4 2016, worth a combined $103M — up 25% from $82.3M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of MRUS and 1 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 2 added.

The largest buyer was Tekla Capital Management, adding an estimated $3.74M. The largest seller was Iguana Healthcare Management, cutting an estimated $4.27M.

  • 11 institutional investors held Merus (MRUS) as of Q4 2016, down from 12 in Q3 2016.
  • Funds reported $103M of Merus stock for Q4 2016, up 25% quarter-over-quarter.
  • 1 fund opened new Merus positions in Q4 2016 and 2 closed out, a net change of -1 holder.
  • The largest Merus buyer in Q4 2016 was Tekla Capital Management, an estimated $3.74M added.
  • The largest Merus seller in Q4 2016 was Iguana Healthcare Management, an estimated $4.27M sold.

Based on aggregated 13F filings for Q4 2016.